DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis

This study has been terminated.
(Study terminated due to slow accrual with no expansion to additional phase.)
Sponsor:
Collaborators:
Enzon Pharmaceuticals, Inc.
Schering-Plough
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00515788
First received: August 13, 2007
Last updated: March 8, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)